Drug profile · INN
alglucosidase alfa
MYOZYME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
alglucosidase alfa (MYOZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: iv (infusion). Current US regulatory status: approved.
Key facts
INN alglucosidase alfa
Brand MYOZYME
Route IV (INFUSION)
Formulation POWDER
ATC code A16AB07
Frequently asked questions
What is alglucosidase alfa?
alglucosidase alfa (MYOZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: iv (infusion). Current US regulatory status: approved.
What is the brand name for alglucosidase alfa?
MYOZYME is a marketed brand name for alglucosidase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alglucosidase alfa?
alglucosidase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.